Who owns Oncothyreon?

Key details on Oncothyreon (Ticker: ONTY)

Who owns Oncothyreon?

Is ONTY a good stock to own? Find out who bought Oncothyreon, who sold Oncothyreon (ONTY) stock, and who holds a large position in Oncothyreon.

Fund Name Number of Shares Share Valuation As Of
BVF 9.00M $15.84M Dec. 31, 2013
QVT Financial 5.70M $10.04M Dec. 31, 2013
First Eagle Investment Management 2.62M $4.62M Dec. 31, 2013
Antipodean Advisors 2.30M $13.77M Sept. 30, 2011
Ayer Capital Management 2.20M $11.30M Sept. 30, 2012
JPMORGAN CHASE & CO 2.05M $3.22M June 30, 2013
BlackRock Institutional Trust Company, N.A. 1.91M $3.35M Dec. 31, 2013
Franklin Resources 1.79M $3.15M Dec. 31, 2013
Jefferies 1.64M $3.14M Dec. 31, 2012
OrbiMed Advisors 1.52M $7.81M Sept. 30, 2012
Deerfield Management Company 1.50M $6.54M March 31, 2012
Vanguard 1.40M $2.43M Dec. 31, 2013
State of Wisconsin Investment Board 1.35M $2.38M Dec. 31, 2013
BAM Management 1.25M $7.46M Sept. 30, 2011
Tang Capital Management 984980 $2.05M March 31, 2013
Adage Capital Partners GP 950000 $1.49M June 30, 2013
Employees Retirement System of Texas 891000 $1.57M Dec. 31, 2013
BlackRock Fund Advisors 861214 $1.77M Sept. 30, 2013
STATE STREET CORPORATION 848145 $1.63M Dec. 31, 2013
Anthion Management 775400 $3.38M March 31, 2012
Broadfin Capital 750000 $1.44M Dec. 31, 2012
SPHERA FUNDS MANAGEMENT 748336 $1.32M Dec. 31, 2013
CITADEL ADVISORS 710761 $1.48M March 31, 2013
Renaissance Technologies 707362 $1.46M Sept. 30, 2013
Sabby Management 659600 $1385 Sept. 30, 2013
Barclays 635247 $603484 Dec. 31, 2013
Dr. Jeffrey R. Jay, M.D. 605774 $1.26M March 31, 2013
Dr. Jeffrey R. Jay, M.D 605774 $1.26M March 31, 2013
SUSQUEHANNA INTERNATIONAL 584716 $1.03M Dec. 31, 2013
NORTHERN TRUST 557255 $869317 June 30, 2013
"Perkins Capital Management, Inc." 554850 $976536 Dec. 31, 2013
GOLDMAN SACHS 554819 $1.14M Sept. 30, 2013
D. E. Shaw & Co 540319 $950961 Dec. 31, 2013
Arrow Capital Management 519400 $3.94M Dec. 31, 2011
FIRST MANHATTAN 518900 $913264 Dec. 31, 2013
Deutsche Bank Aktiengesellschaft 502202 $883875 Dec. 31, 2013
Perceptive Advisors 500000 $880000 Dec. 31, 2013
PointState Capital 500000 $1.03M Sept. 30, 2013
Hudson Bay Capital Management 413100 $1.80M March 31, 2012
683 Capital Management 404300 $3.06M Dec. 31, 2011
Millennium Management 400000 $704000 Dec. 31, 2013
Balyasny Asset Management 360200 $2.73M Dec. 31, 2011
Cowen 350000 $616000 Dec. 31, 2013
Straus Capital Management 350000 $1.80M Sept. 30, 2012

Who sold Oncothyreon?

Fund Name Date Sold Number of Shares Sold Share Valuation
Black Horse Capital Management June 30, 2011 1.12M $10.32M
Driehaus Capital Management June 30, 2011 472932 $4.35M